Advance in the mechanism of protective effects of SGLT2 inhibitor on diabetic kidney disease
Shi-zhe GUO
DOI: https://doi.org/10.3969/j.issn.1672-8467.2018.02.017
2018-01-01
Abstract:Diabetic kidney disease DKD) is one of the major causes for end-stage renal disease (ESRD),which has been the focus of both clinical and basic research.Sodium-glucose cotransport 2 (SGLT2) inhibitors are a new type of anti-diabetic drugs,which also showed reno-proteetive effects.The potential mechanisms include decreasing plasma glucose,improving glomerular hyperfiltration,reducing oxidative stress,alleviating tubulointerstitial injury,suppressing inflammation and fibrosis,decreasing the level of uric acid,and etc.This review focuses on the advance in the mechanism of protective effects of SGLT2 inhibitor on DKD.
What problem does this paper attempt to address?